Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clonal Dynamics of FLT3 -ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin

Romane Joudinaud, Augustin Boudry, Laurène Fenwarth, Sandrine Geffroy, Mikaël Salson, Herve Dombret, Céline Berthon, Arnaud Pigneux, Delphine Lebon, Lamya Haddaoui, Raphael Itzykson, Christian Recher, Audrey Bidet, Eric Delabesse, Mathilde Hunault, Claude Preudhomme, Nicolas Duployez, Pierre-Yves Dumas

Blood (2023) 142 (Supplement 1): 976.

https://doi.org/10.1182/blood-2023-182018

Published: 2023

Journal Articles

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia

Blood (2021) 137 (10): 1424–1428.

https://doi.org/10.1182/blood.2020005756

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group

Blood (2017) 130 (Supplement 1): 403.

https://doi.org/10.1182/blood.V130.Suppl_1.403.403

Published: 2017

Journal Articles

Clofarabine-Based Consolidation Improves Relapse-Free Survival of Patients with Acute Myeloid Leukemia with Complex or Micro-Complex Karyotype: Results from the Randomized ALFA-0702 Study

Laurène Fenwarth, MSc, MD, Nicolas Duployez, PharmD, PhD, Xavier Thomas, MD, Nicolas Boissel, MD PhD, Sandrine Geffroy, PhD, Alice Marceau-Renaut, PharmD, Denis Caillot, MD, Emmanuel Raffoux, MD, Emilie Lemasle, MD, Jean-Pierre Marolleau, MD PhD, Céline Berthon, MD PhD, Meyling H. Cheok, MSPharm, PhD, Pauline Peyrouze, Arnaud Pigneux, MD PhD, Norbert Vey, Karine Celli-Lebras, CRA, Christine Terré, PharmD, PhD, Claude Preudhomme, PharmD, PhD, Herve Dombret, MD

Blood (2017) 130 (Supplement 1): 465.

https://doi.org/10.1182/blood.V130.Suppl_1.465.465

Published: 2017

Journal Articles

TP53 Mutation in Waldenstrom Macroglobulinemia

Stephanie Poulain, Christophe Roumier, MD, Elisabeth Bertrand, Aline Renneville, MD, Sabine Tricot, Aurelie Caillault Venet, Sandrine Geffroy, PhD, Morgan Nudel, Charles Herbaux, MD, Stéphanie Guidez, Claude Preudhomme, MD PhD, Xavier Leleu

Blood (2016) 128 (22): 4092.

https://doi.org/10.1182/blood.V128.22.4092.4092

Published: 2016

Journal Articles

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Blood (2016) 127 (20): 2451–2459.

https://doi.org/10.1182/blood-2015-12-688705

Published: 2016

Includes: Supplemental data

Journal Articles

Inversely to DNMT3A, IDH1/IDH2 Are Good Targets for Monitoring Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML): A Pilot Study of the ALFA Group

Blood (2014) 124 (21): 2327.

https://doi.org/10.1182/blood.V124.21.2327.2327

Published: 2014

Journal Articles

Results of the “Evaluation of NGS in AML-Diagnostics (ELAN)” Study – an Inter-Laboratory Comparison Performed in 10 European Laboratories

Blood (2014) 124 (21): 2374.

https://doi.org/10.1182/blood.V124.21.2374.2374

Published: 2014

Journal Articles

Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia

Stephanie Poulain, Christophe Roumier, Emmanuelle Doye, Martin Figeac, Aurélie Caillault, Sandrine Geffroy, Olivier Nibourel, PhD, Frederic Lepretre, Agnes Daudignon, Sabine Tricot, MD, Patrick Duthilleul, Claude Preudhomme, PharmD, PhD, Xavier Leleu, MD

Blood (2014) 124 (21): 1627.

https://doi.org/10.1182/blood.V124.21.1627.1627

Published: 2014

Journal Articles

Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)

Blood (2014) 124 (21): 482.

https://doi.org/10.1182/blood.V124.21.482.482

Published: 2014

Journal Articles

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/ RUNX1-RUNX1T1 chromosomal translocations

Jean-Baptiste Micol, Nicolas Duployez, Nicolas Boissel, Arnaud Petit, Sandrine Geffroy, Olivier Nibourel, Catherine Lacombe, Helene Lapillonne, Pascaline Etancelin, Martin Figeac, Aline Renneville, Sylvie Castaigne, Guy Leverger, Norbert Ifrah, Hervé Dombret, Claude Preudhomme, Omar Abdel-Wahab, Eric Jourdan

Blood (2014) 124 (9): 1445–1449.

https://doi.org/10.1182/blood-2014-04-571018

Published: 2014

Includes: Supplemental data

Journal Articles

SNP Array Analysis in Acute Myeloid Leukemia Reveals Frequent and Recurrent Acquired Genetic Alterations Linked to Prognosis: a Study of the ALFA Group

Olivier Nibourel, Christophe Roumier, Samuel Quentin, Sandrine Geffroy, Antonio Alberdi, Aline Renneville, Céline Berthon, MD, Celine Villenet, Martin Figeac, Herve Dombret, Jean Soulier, MD, Claude Preudhomme, Meyling Cheok

Blood (2011) 118 (21): 2533.

https://doi.org/10.1182/blood.V118.21.2533.2533

Published: 2011

Journal Articles

Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group

Blood (2010) 116 (21): 4171.

https://doi.org/10.1182/blood.V116.21.4171.4171

Published: 2010

Journal Articles

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

Blood (2010) 116 (7): 1132–1135.

https://doi.org/10.1182/blood-2009-07-234484

Published: 2010

Includes: Supplemental data

Journal Articles

Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).

Blood (2009) 114 (22): 163.

https://doi.org/10.1182/blood.V114.22.163.163

Published: 2009

Journal Articles

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Catherine Roche-Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, Nathalie Philippe, Sandrine Geffroy, Jean-Luc Laï, Franck-Emmanuel Nicolini, Claude Preudhomme

Blood (2008) 111 (7): 3735–3741.

https://doi.org/10.1182/blood-2007-07-102533

Published: 2008

Includes: Supplemental data

Journal Articles

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Catherine Roche-Lestienne, PhD, Laureline Deluche, MD, Selim Corm, MD, Isabelle Tigaud, MD, Sami Joha, PhD, Nathalie Philippe, PhD, Sandrine Geffroy, PhD, Jean-Luc Lai, PhD, Franck Nicolini, MD, PhD, Claude Preudhomme, MD, PhD

Blood (2007) 110 (11): 2786.

https://doi.org/10.1182/blood.V110.11.2786.2786

Published: 2007

Journal Articles

Molecular Characterization of Genomic Structural Alterations through CGH Arrays in Acute Myeloid Leukemia with Normal Cytogenetic Findings.

Christophe Roumier, MD, Sandrine Geffroy, PHD, Olivier Nibourel, MD, Sabine Quief, Celine Villenet, Aline Reneville, MD, Valeria Biggio, PHD, Jean-Luc Laï, PHD, Jean-Pierre Kerckaert, PHD, Claude Preudhomme, MD/PHD

Blood (2006) 108 (11): 105.

https://doi.org/10.1182/blood.V108.11.105.105

Published: 2006

NARROW

Clonal Dynamics of FLT3 -ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia

Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group

Clofarabine-Based Consolidation Improves Relapse-Free Survival of Patients with Acute Myeloid Leukemia with Complex or Micro-Complex Karyotype: Results from the Randomized ALFA-0702 Study

TP53 Mutation in Waldenstrom Macroglobulinemia

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Inversely to DNMT3A, IDH1/IDH2 Are Good Targets for Monitoring Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML): A Pilot Study of the ALFA Group

Results of the “Evaluation of NGS in AML-Diagnostics (ELAN)” Study – an Inter-Laboratory Comparison Performed in 10 European Laboratories

Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia

Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/ RUNX1-RUNX1T1 chromosomal translocations

SNP Array Analysis in Acute Myeloid Leukemia Reveals Frequent and Recurrent Acquired Genetic Alterations Linked to Prognosis: a Study of the ALFA Group

Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Molecular Characterization of Genomic Structural Alterations through CGH Arrays in Acute Myeloid Leukemia with Normal Cytogenetic Findings.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only